Leadership Overview
ClinChoice has 6 executives leading key functions including corporate strategy, international operations, global governance, regional management, clinical revenue, and biometrics.
Focused on accelerating drug and device approvals, ClinChoice delivers comprehensive research services to improve global health outcomes through rigorous scientific standards and efficient development pathways.
Focused on accelerating drug and device approvals, ClinChoice delivers comprehensive research services to improve global health outcomes through rigorous scientific standards and efficient development pathways.
Leadership Roles at ClinChoice
Kevin Xu - Chairman & Chief Executive Officer
Kevin Xu, the Chairman & Chief Executive Officer at ClinChoice, directs the overarching corporate strategy and long-term vision for the organization. By overseeing the expansion of full-service CRO capabilities, the Chairman & Chief Executive Officer ensures that drug and device development processes meet stringent global regulatory requirements. This leadership role involves constant engagement with the Board to align operational goals with the mission of accelerating market access for life-saving therapies. Kevin Xu maintains a focus on scaling infrastructure to support complex clinical trials across diverse therapeutic areas. Through the implementation of high-level governance frameworks, the Chairman & Chief Executive Officer drives organizational excellence and fosters a culture of innovation. Ultimately, the executive secures the company's position as a premier partner for pharmaceutical and medical device companies seeking efficient, reliable, and compliant research solutions on a global scale.
John Balian - ClinChoice International Chief Executive Officer
John Balian, the ClinChoice International Chief Executive Officer at ClinChoice, manages the strategic growth and operational execution of international business units. Overseeing the expansion of service offerings across diverse global markets, the ClinChoice International Chief Executive Officer ensures that regional teams maintain alignment with the core mission of accelerating drug and device approvals. This leadership role involves coordinating cross-border clinical operations to optimize efficiency and regulatory compliance for international clients. John Balian drives the integration of local expertise into the broader global framework, facilitating seamless project delivery. By monitoring market trends and competitive dynamics, the ClinChoice International Chief Executive Officer identifies opportunities for sustainable growth and service enhancement. Through the management of international partnerships and client relationships, Balian strengthens the company's footprint, ensuring that global research initiatives consistently deliver high-quality data and support for medical advancements worldwide.
Ling Zhen - Global Chief Executive Officer & Chairman, Board
Ling Zhen, the Global Chief Executive Officer & Chairman, Board at ClinChoice, architects the strategic direction and governance standards for the entire organization. Overseeing global operations, the Global Chief Executive Officer & Chairman, Board ensures that all clinical research activities adhere to the highest quality benchmarks while accelerating time-to-market for critical medical products. This leadership role involves guiding the Board through complex decision-making processes regarding capital allocation and long-term business development. Ling Zhen drives the implementation of advanced operational models that enhance productivity across all service lines. By fostering collaboration between internal departments and external stakeholders, the Global Chief Executive Officer & Chairman, Board maintains a focus on delivering superior value to clients. Through the oversight of global performance metrics, Zhen ensures that the company remains at the forefront of the CRO industry, consistently contributing to a safer and better world.

Tiepu Liu - President, Global Biometrics
Tiepu Liu, the President, Global Biometrics at ClinChoice, leads the strategic development and execution of biostatistical and data management services. Overseeing the global biometrics division, the President, Global Biometrics ensures that all clinical data analysis meets the rigorous standards required for regulatory submissions of drugs and devices. This leadership role involves managing large-scale data operations and implementing advanced analytical methodologies to support clinical trial success. Tiepu Liu drives the integration of innovative technology into biometric processes to enhance data accuracy and speed. By collaborating with other C-suite leaders, the President, Global Biometrics aligns data-driven insights with the company's overall mission of accelerating market approvals. Through the supervision of global teams, Liu ensures that biometrics services remain a core strength of the organization. The President, Global Biometrics consistently delivers high-quality statistical support, enabling clients to navigate complex regulatory environments with confidence and precision.

Stephen Abella - Project Coordinator & Chief Revenue Officer, Clinical Operations Qualified Person For Lto
Stephen Abella, the Project Coordinator & Chief Revenue Officer, Clinical Operations Qualified Person For Lto at ClinChoice, directs the financial strategy and revenue growth initiatives within the clinical operations division. Overseeing the alignment of project coordination with revenue targets, the Project Coordinator & Chief Revenue Officer, Clinical Operations Qualified Person For Lto ensures that operational activities remain profitable while meeting client expectations for drug and device approval timelines. This leadership role involves managing the financial health of clinical projects and ensuring that all operations comply with the necessary regulatory qualifications. Stephen Abella drives the development of revenue-generating strategies that leverage the company's full-service capabilities. By monitoring project performance and resource allocation, the Project Coordinator & Chief Revenue Officer, Clinical Operations Qualified Person For Lto optimizes the financial outcomes of complex research programs. Abella ensures that the company maintains a strong competitive position through disciplined financial management and operational efficiency.
Davit Abrahamyan - Managing Director
Davit Abrahamyan, the Managing Director at ClinChoice, oversees regional operational performance and ensures the successful delivery of clinical research services. Managing the day-to-day execution of complex projects, the Managing Director aligns local resources with the company's global standards for drug and device development. This leadership role involves supervising cross-functional teams to maintain strict adherence to regulatory timelines and quality protocols. Davit Abrahamyan drives the optimization of operational workflows to increase efficiency and reduce development cycles for clients. By coordinating with other senior leaders, the Managing Director ensures that regional initiatives support the broader corporate strategy. Through the management of client portfolios and project budgets, Abrahamyan secures consistent service delivery and operational excellence. The Managing Director plays a vital role in maintaining the company's reputation for reliability and scientific rigor within the competitive landscape of clinical research and development.
Explore Leadership Teams in Business Services
Brookhaven National Laboratory delivers discovery science and transformative technology to power and secure the nations future. Primarily supported by the U.S. Department of Energys (DOE) Office of Science, Brookhaven Lab is a multidisciplinary laboratory with seven Nobel Prize-winning discoveries, 37 R&D 100 Awards, and more than 70 years of pioneering research.
Company Leadership PO
KR
AS
AmSpec provides expert testing, inspection, and certification (TIC) services globally, catering to sectors such as energy, agriculture, chemicals, metals, and sustainability. With a vast network of state-of-the-art laboratories and hundreds of locations worldwide, AmSpec ensures high-quality, accurate, and precise services. The company is committed to helping clients meet industry standards and regulatory compliance while maintaining a focus on sustainability. AmSpec's highly-trained staff and stringent quality assurance programs reinforce its reputation as a trusted service provider in the TIC sector.
Company Leadership
RS

MV
The Interdisciplinary Computational Vision Lab, established in 2006 at Ben-Gurion University, specializes in computational vision and various aspects of vision sciences. The lab conducts research in theoretical computer vision, human perception, visual psychophysics, visual neuroscience, and applied machine vision. Its mission is to enhance the understanding of biological vision, particularly human vision, while exploring theoretical foundations and practical applications in machine vision. The lab actively seeks talented graduate students passionate about vision sciences to join its research initiatives.
Company Leadership BR
DC
YR
Argonne National Laboratory is a Department of Energy science and engineering research laboratory headquartered in Lemont, Illinois. Its research spans physics, chemistry, nuclear energy, transportation, computing, materials science, and other fields, supported by specialized research facilities and scientific capabilities. The laboratory serves researchers from across the United States and around the world, as well as government, universities, businesses, and community audiences through collaborative research, user facilities, educational programs, and technology partnerships.
Company Leadership DH
MS
DR